SARS‐CoV‐2 infection during pregnancy and perinatal outcomes in Estonia in 2020 and 2021: A register‐based study
Acta Obstetricia et Gynecologica Scandinavica · 2024
DOI: 10.1111/aogs.14721 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Piret Veerus und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia. Hauptthemen laut MEDLINE: Premature Birth, Pre-Eclampsia, COVID-19, Perinatal Death. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Data from different countries show partly controversial impact of SARS‐CoV‐2 infection on pregnancy outcomes. A nationwide register‐based study was conducted in Estonia to assess the impact of SARS‐CoV‐2 infection at any time during pregnancy on stillbirth, perinatal mortality, Apgar score at 5 minutes, cesarean section rates, rates of preterm birth and preeclampsia. Material and methods Data on all newborns and their mothers were obtained from the Estonian Medical Birth Registry, and data on SARS‐CoV‐2 testing dates, test results and vaccination dates against SARS‐CoV‐2 from the Estonian Health Information System. Altogether, 26 211 births in 2020 and 2021 in Estonia were included. All analyses were performed per newborn. Odds ratios with 95% confidence intervals (CI) were analyzed for all outcomes, adjusted for mother's place of residence, body mass index, age of mother at delivery and hypertension and for all the aforementioned variables together with mother's vaccination status using data from 2021 when vaccinations against SARS‐CoV‐2 became available. For studying the effect of a positive SARS‐CoV‐2 test during pregnancy on preeclampsia, hypertension was omitted from the models to avoid overadjustment.
Results
SARS‐CoV‐2 infection during pregnancy was associated with an increased risk of stillbirth (adjusted odds ratio [aOR] 2.81; 95% CI 1.37–5.74) and perinatal mortality (aOR 2.34; 95% CI 1.20–4.56) but not with a lower Apgar score at 5 minutes, higher risk of cesarean section, preeclampsia or preterm birth. Vaccination slightly decreased the impact of SARS‐CoV‐2 infection during pregnancy on perinatal mortality.
Conclusions
A positive SARS‐CoV‐2 test during pregnancy was associated with higher rates of stillbirth and perinatal mortality in Estonia but was not associated with change in preeclampsia, cesarean section or preterm birth rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, National Institute for Health Development, Tallinn, Estonia.
- West-Tallinn Central Hospital Women's Clinic, Tallinn, Estonia.
- Estonian Medical Birth Registry, National Institute for Health Development, Tallinn, Estonia.
- University of Tartu, Tartu, Estonia.
- Tartu University Hospital, Tartu, Estonia.
ORCID-Profile: Piret Veerus
Zitieren
APA
Veerus, P., Nõmm, O., Innos, K., Allvee, K., & Karro, H. (2024). SARS‐CoV‐2 infection during pregnancy and perinatal outcomes in Estonia in 2020 and 2021: A register‐based study. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14721
Vancouver
Veerus P, Nõmm O, Innos K, Allvee K, Karro H. SARS‐CoV‐2 infection during pregnancy and perinatal outcomes in Estonia in 2020 and 2021: A register‐based study. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14721
BibTeX
@article{Veerus2024,
author = {Veerus, Piret and Nõmm, Oskar and Innos, Kaire and Allvee, Kärt and Karro, Helle},
title = {SARS‐CoV‐2 infection during pregnancy and perinatal outcomes in Estonia in 2020 and 2021: A register‐based study},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2024},
doi = {10.1111/aogs.14721}
}
EUVIMED